Marisa holds an MS in Cellular and Molecular Pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. She specializes in cancer biology, immunology, and genetics. Marisa began working with BioNews in 2018, and has written about science and health for SelfHacked and the Genetics Society of America. She also writes/composes musicals and coaches the University of Pittsburgh fencing club.
A study of Chinese children with X-linked hypophosphatemia (XLH) found 28 new mutations in the PHEX gene that cause the rare and progressive inherited disorder. While uncommon genetic alterations were ... Read more
The Committee for Medicinal Products for Human Use (CHMP), an arm of the European Medicines Agency, has recommended that the approval of Crysvita (burosumab) be expanded to include all adolescents and adults with ... Read more
If combined with an approach that targets hallmark abnormalities in X-linked hypophosphatemia (XLH), treatment with growth hormone could normalize bone growth and structure in these patients, a study in mice ... Read more